Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

The Scientist

» cancer, disease/medicine and microbiology

Most Recent

image: Nervous Mice Get Worse Cancer

Nervous Mice Get Worse Cancer

By | May 3, 2012

Anxious mice are more likely to come down with aggressive skin cancer than those who show less stress on behavioral tests.

0 Comments

image: FDA Disputes Data Under-Reporting

FDA Disputes Data Under-Reporting

By | May 2, 2012

The FDA and NIH dispute reports that clinical trial data is being under-reported.

0 Comments

image: Telomere Basics

Telomere Basics

By | May 1, 2012

Telomeres are repetitive, noncoding sequences that cap the ends of linear chromosomes. They consist of hexameric nucleotide sequences (TTAGGG in humans) repeated hundreds to thousands of times. 

4 Comments

Contributors

May 1, 2012

Meet some of the people featured in the April 2012 issue of The Scientist.

0 Comments

image: Designing Transition-State Inhibitors

Designing Transition-State Inhibitors

By | May 1, 2012

A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. 

0 Comments

image: Treating Fat with Fat

Treating Fat with Fat

By | May 1, 2012

Is brown fat ready for therapeutic prime time?

22 Comments

image: Tumor Turnabout

Tumor Turnabout

By | May 1, 2012

A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.

4 Comments

image: Bubble Vision

Bubble Vision

By | May 1, 2012

Turning a liability into an asset, cryo-electron microscopists exploit an artifact to probe protein structure.

0 Comments

image: Data Diving

Data Diving

By | May 1, 2012

What lies untapped beneath the surface of published clinical trial analyses could rock the world of independent review.

28 Comments

image: Freezing Time

Freezing Time

By | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

Advertisement
Lonza Group
Lonza Group

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

Advertisement
Advertisement
LabX
LabX
RayBioTech